 | • レポートコード：QYR2104Z4351 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、91ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療 |
| Single User | ￥546,000 (USD3,900) | ▷ お問い合わせ |
| Multi User/Five User | ￥819,000 (USD5,850) | ▷ お問い合わせ |
| Enterprise License（同一法人内共有可） | ￥1,092,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査資料では、骨肉腫のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（髄内骨肉腫、傍皮質骨肉腫、骨格外骨肉腫）、用途別市場規模（病院、診療所、その他）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・骨肉腫の市場動向 ・企業の競争状況、市場シェア ・骨肉腫の種類別市場規模（髄内骨肉腫、傍皮質骨肉腫、骨格外骨肉腫） ・骨肉腫の用途別市場規模（病院、診療所、その他） ・骨肉腫の北米市場規模2016-2027（アメリカ、カナダ） ・骨肉腫のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・骨肉腫のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・骨肉腫の中南米市場規模2016-2027（メキシコ、ブラジル） ・骨肉腫の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Pfizer、Spectrum Pharmaceuticals、Hikma Pharmaceuticals、Baxter、Isofol、Advaxis、Bellicum Pharmaceuticals、Novartis） ・結論 |
An osteosarcoma (OS) is a cancerous tumor in a bone. Specifically, it is an aggressive malignant neoplasm that arises from primitive transformed cells of mesenchymal origin (and thus a sarcoma) and that exhibits osteoblastic differentiation and produces malignant osteoid. Osteosarcoma is the most common histological form of primary bone cancer. It is most prevalent in teenagers and young adults.
Osteosarcoma is the eighth-most common form of childhood cancer, comprising 2.4% of all malignancies in pediatric patients, and about 20% of all primary bone cancers. Incidence rates for osteosarcoma in U.S. patients under 20 years of age are estimated at 5.0 per million per year in the general population, with a slight variation between individuals of black, Hispanic, and white ethnicities (6.8, 6.5, and 4.6 per million per year, respectively). It is slightly more common in males (5.4 per million per year) than in females (4.0 per million per year).
Market Analysis and Insights: Global Osteosarcoma Market
The global Osteosarcoma market size is projected to reach US$ 654.8 million by 2026, from US$ 514.9 million in 2019, at a CAGR of 3.5% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Osteosarcoma market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Osteosarcoma market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Osteosarcoma market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Osteosarcoma market.
Global Osteosarcoma Scope and Market Size
Osteosarcoma market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Osteosarcoma market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Intramedullary Osteosarcoma
Juxtacortical Osteosarcoma
Extraskeletal Osteosarcoma
Segment by Application
Hospital
Clinic
Others
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Pfizer
Spectrum Pharmaceuticals
Hikma Pharmaceuticals
Baxter
Isofol
Advaxis
Bellicum Pharmaceuticals
Novartis
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Osteosarcoma Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Intramedullary Osteosarcoma
1.2.3 Juxtacortical Osteosarcoma
1.2.4 Extraskeletal Osteosarcoma
1.3 Market by Application
1.3.1 Global Osteosarcoma Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Osteosarcoma Market Perspective (2016-2027)
2.2 Osteosarcoma Growth Trends by Regions
2.2.1 Osteosarcoma Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Osteosarcoma Historic Market Share by Regions (2016-2021)
2.2.3 Osteosarcoma Forecasted Market Size by Regions (2022-2027)
2.3 Osteosarcoma Industry Dynamic
2.3.1 Osteosarcoma Market Trends
2.3.2 Osteosarcoma Market Drivers
2.3.3 Osteosarcoma Market Challenges
2.3.4 Osteosarcoma Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Osteosarcoma Players by Revenue
3.1.1 Global Top Osteosarcoma Players by Revenue (2016-2021)
3.1.2 Global Osteosarcoma Revenue Market Share by Players (2016-2021)
3.2 Global Osteosarcoma Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Osteosarcoma Revenue
3.4 Global Osteosarcoma Market Concentration Ratio
3.4.1 Global Osteosarcoma Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Osteosarcoma Revenue in 2020
3.5 Osteosarcoma Key Players Head office and Area Served
3.6 Key Players Osteosarcoma Product Solution and Service
3.7 Date of Enter into Osteosarcoma Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Osteosarcoma Breakdown Data by Type
4.1 Global Osteosarcoma Historic Market Size by Type (2016-2021)
4.2 Global Osteosarcoma Forecasted Market Size by Type (2022-2027)
5 Osteosarcoma Breakdown Data by Application
5.1 Global Osteosarcoma Historic Market Size by Application (2016-2021)
5.2 Global Osteosarcoma Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Osteosarcoma Market Size (2016-2027)
6.2 North America Osteosarcoma Market Size by Type
6.2.1 North America Osteosarcoma Market Size by Type (2016-2021)
6.2.2 North America Osteosarcoma Market Size by Type (2022-2027)
6.2.3 North America Osteosarcoma Market Size by Type (2016-2027)
6.3 North America Osteosarcoma Market Size by Application
6.3.1 North America Osteosarcoma Market Size by Application (2016-2021)
6.3.2 North America Osteosarcoma Market Size by Application (2022-2027)
6.3.3 North America Osteosarcoma Market Size by Application (2016-2027)
6.4 North America Osteosarcoma Market Size by Country
6.4.1 North America Osteosarcoma Market Size by Country (2016-2021)
6.4.2 North America Osteosarcoma Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada
7 Europe
7.1 Europe Osteosarcoma Market Size (2016-2027)
7.2 Europe Osteosarcoma Market Size by Type
7.2.1 Europe Osteosarcoma Market Size by Type (2016-2021)
7.2.2 Europe Osteosarcoma Market Size by Type (2022-2027)
7.2.3 Europe Osteosarcoma Market Size by Type (2016-2027)
7.3 Europe Osteosarcoma Market Size by Application
7.3.1 Europe Osteosarcoma Market Size by Application (2016-2021)
7.3.2 Europe Osteosarcoma Market Size by Application (2022-2027)
7.3.3 Europe Osteosarcoma Market Size by Application (2016-2027)
7.4 Europe Osteosarcoma Market Size by Country
7.4.1 Europe Osteosarcoma Market Size by Country (2016-2021)
7.4.2 Europe Osteosarcoma Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Osteosarcoma Market Size (2016-2027)
8.2 Asia-Pacific Osteosarcoma Market Size by Type
8.2.1 Asia-Pacific Osteosarcoma Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Osteosarcoma Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Osteosarcoma Market Size by Type (2016-2027)
8.3 Asia-Pacific Osteosarcoma Market Size by Application
8.3.1 Asia-Pacific Osteosarcoma Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Osteosarcoma Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Osteosarcoma Market Size by Application (2016-2027)
8.4 Asia-Pacific Osteosarcoma Market Size by Region
8.4.1 Asia-Pacific Osteosarcoma Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Osteosarcoma Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Osteosarcoma Market Size (2016-2027)
9.2 Latin America Osteosarcoma Market Size by Type
9.2.1 Latin America Osteosarcoma Market Size by Type (2016-2021)
9.2.2 Latin America Osteosarcoma Market Size by Type (2022-2027)
9.2.3 Latin America Osteosarcoma Market Size by Type (2016-2027)
9.3 Latin America Osteosarcoma Market Size by Application
9.3.1 Latin America Osteosarcoma Market Size by Application (2016-2021)
9.3.2 Latin America Osteosarcoma Market Size by Application (2022-2027)
9.3.3 Latin America Osteosarcoma Market Size by Application (2016-2027)
9.4 Latin America Osteosarcoma Market Size by Country
9.4.1 Latin America Osteosarcoma Market Size by Country (2016-2021)
9.4.2 Latin America Osteosarcoma Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Osteosarcoma Market Size (2016-2027)
10.2 Middle East & Africa Osteosarcoma Market Size by Type
10.2.1 Middle East & Africa Osteosarcoma Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Osteosarcoma Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Osteosarcoma Market Size by Type (2016-2027)
10.3 Middle East & Africa Osteosarcoma Market Size by Application
10.3.1 Middle East & Africa Osteosarcoma Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Osteosarcoma Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Osteosarcoma Market Size by Application (2016-2027)
10.4 Middle East & Africa Osteosarcoma Market Size by Country
10.4.1 Middle East & Africa Osteosarcoma Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Osteosarcoma Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Pfizer
11.1.1 Pfizer Company Details
11.1.2 Pfizer Business Overview
11.1.3 Pfizer Osteosarcoma Introduction
11.1.4 Pfizer Revenue in Osteosarcoma Business (2016-2021)
11.1.5 Pfizer Recent Development
11.2 Spectrum Pharmaceuticals
11.2.1 Spectrum Pharmaceuticals Company Details
11.2.2 Spectrum Pharmaceuticals Business Overview
11.2.3 Spectrum Pharmaceuticals Osteosarcoma Introduction
11.2.4 Spectrum Pharmaceuticals Revenue in Osteosarcoma Business (2016-2021)
11.2.5 Spectrum Pharmaceuticals Recent Development
11.3 Hikma Pharmaceuticals
11.3.1 Hikma Pharmaceuticals Company Details
11.3.2 Hikma Pharmaceuticals Business Overview
11.3.3 Hikma Pharmaceuticals Osteosarcoma Introduction
11.3.4 Hikma Pharmaceuticals Revenue in Osteosarcoma Business (2016-2021)
11.3.5 Hikma Pharmaceuticals Recent Development
11.4 Baxter
11.4.1 Baxter Company Details
11.4.2 Baxter Business Overview
11.4.3 Baxter Osteosarcoma Introduction
11.4.4 Baxter Revenue in Osteosarcoma Business (2016-2021)
11.4.5 Baxter Recent Development
11.5 Isofol
11.5.1 Isofol Company Details
11.5.2 Isofol Business Overview
11.5.3 Isofol Osteosarcoma Introduction
11.5.4 Isofol Revenue in Osteosarcoma Business (2016-2021)
11.5.5 Isofol Recent Development
11.6 Advaxis
11.6.1 Advaxis Company Details
11.6.2 Advaxis Business Overview
11.6.3 Advaxis Osteosarcoma Introduction
11.6.4 Advaxis Revenue in Osteosarcoma Business (2016-2021)
11.6.5 Advaxis Recent Development
11.7 Bellicum Pharmaceuticals
11.7.1 Bellicum Pharmaceuticals Company Details
11.7.2 Bellicum Pharmaceuticals Business Overview
11.7.3 Bellicum Pharmaceuticals Osteosarcoma Introduction
11.7.4 Bellicum Pharmaceuticals Revenue in Osteosarcoma Business (2016-2021)
11.7.5 Bellicum Pharmaceuticals Recent Development
11.8 Novartis
11.8.1 Novartis Company Details
11.8.2 Novartis Business Overview
11.8.3 Novartis Osteosarcoma Introduction
11.8.4 Novartis Revenue in Osteosarcoma Business (2016-2021)
11.8.5 Novartis Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Osteosarcoma Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Intramedullary Osteosarcoma
Table 3. Key Players of Juxtacortical Osteosarcoma
Table 4. Key Players of Extraskeletal Osteosarcoma
Table 5. Global Osteosarcoma Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Osteosarcoma Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Osteosarcoma Market Size by Regions (2016-2021) & (US$ Million)
Table 8. Global Osteosarcoma Market Share by Regions (2016-2021)
Table 9. Global Osteosarcoma Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 10. Global Osteosarcoma Market Share by Regions (2022-2027)
Table 11. Osteosarcoma Market Trends
Table 12. Osteosarcoma Market Drivers
Table 13. Osteosarcoma Market Challenges
Table 14. Osteosarcoma Market Restraints
Table 15. Global Osteosarcoma Revenue by Players (2016-2021) & (US$ Million)
Table 16. Global Osteosarcoma Market Share by Players (2016-2021)
Table 17. Global Top Osteosarcoma Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Osteosarcoma as of 2020)
Table 18. Ranking of Global Top Osteosarcoma Companies by Revenue (US$ Million) in 2020
Table 19. Global 5 Largest Players Market Share by Osteosarcoma Revenue (CR5 and HHI) & (2016-2021)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Osteosarcoma Product Solution and Service
Table 22. Date of Enter into Osteosarcoma Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Osteosarcoma Market Size by Type (2016-2021) (US$ Million)
Table 25. Global Osteosarcoma Revenue Market Share by Type (2016-2021)
Table 26. Global Osteosarcoma Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 27. Global Osteosarcoma Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 28. Global Osteosarcoma Market Size Share by Application (2016-2021) & (US$ Million)
Table 29. Global Osteosarcoma Revenue Market Share by Application (2016-2021)
Table 30. Global Osteosarcoma Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 31. Global Osteosarcoma Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 32. North America Osteosarcoma Market Size by Type (2016-2021) (US$ Million)
Table 33. North America Osteosarcoma Market Size by Type (2022-2027) & (US$ Million)
Table 34. North America Osteosarcoma Market Size by Application (2016-2021) (US$ Million)
Table 35. North America Osteosarcoma Market Size by Application (2022-2027) & (US$ Million)
Table 36. North America Osteosarcoma Market Size by Country (2016-2021) & (US$ Million)
Table 37. North America Osteosarcoma Market Size by Country (2022-2027) & (US$ Million)
Table 38. Europe Osteosarcoma Market Size by Type (2016-2021) (US$ Million)
Table 39. Europe Osteosarcoma Market Size by Type (2022-2027) & (US$ Million)
Table 40. Europe Osteosarcoma Market Size by Application (2016-2021) (US$ Million)
Table 41. Europe Osteosarcoma Market Size by Application (2022-2027) & (US$ Million)
Table 42. Europe Osteosarcoma Market Size by Country (2016-2021) & (US$ Million)
Table 43. Europe Osteosarcoma Market Size by Country (2022-2027) & (US$ Million)
Table 44. Asia-Pacific Osteosarcoma Market Size by Type (2016-2021) (US$ Million)
Table 45. Asia-Pacific Osteosarcoma Market Size by Type (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Osteosarcoma Market Size by Application (2016-2021) (US$ Million)
Table 47. Asia-Pacific Osteosarcoma Market Size by Application (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Osteosarcoma Market Size by Region (2016-2021) & (US$ Million)
Table 49. Asia-Pacific Osteosarcoma Market Size by Region (2022-2027) & (US$ Million)
Table 50. Latin America Osteosarcoma Market Size by Type (2016-2021) (US$ Million)
Table 51. Latin America Osteosarcoma Market Size by Type (2022-2027) & (US$ Million)
Table 52. Latin America Osteosarcoma Market Size by Application (2016-2021) (US$ Million)
Table 53. Latin America Osteosarcoma Market Size by Application (2022-2027) & (US$ Million)
Table 54. Latin America Osteosarcoma Market Size by Country (2016-2021) & (US$ Million)
Table 55. Latin America Osteosarcoma Market Size by Country (2022-2027) & (US$ Million)
Table 56. Middle East & Africa Osteosarcoma Market Size by Type (2016-2021) (US$ Million)
Table 57. Middle East & Africa Osteosarcoma Market Size by Type (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Osteosarcoma Market Size by Application (2016-2021) (US$ Million)
Table 59. Middle East & Africa Osteosarcoma Market Size by Application (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Osteosarcoma Market Size by Country (2016-2021) & (US$ Million)
Table 61. Middle East & Africa Osteosarcoma Market Size by Country (2022-2027) & (US$ Million)
Table 62. Pfizer Company Details
Table 63. Pfizer Business Overview
Table 64. Pfizer Osteosarcoma Product
Table 65. Pfizer Revenue in Osteosarcoma Business (2016-2021) & (US$ Million)
Table 66. Pfizer Recent Development
Table 67. Spectrum Pharmaceuticals Company Details
Table 68. Spectrum Pharmaceuticals Business Overview
Table 69. Spectrum Pharmaceuticals Osteosarcoma Product
Table 70. Spectrum Pharmaceuticals Revenue in Osteosarcoma Business (2016-2021) & (US$ Million)
Table 71. Spectrum Pharmaceuticals Recent Development
Table 72. Hikma Pharmaceuticals Company Details
Table 73. Hikma Pharmaceuticals Business Overview
Table 74. Hikma Pharmaceuticals Osteosarcoma Product
Table 75. Hikma Pharmaceuticals Revenue in Osteosarcoma Business (2016-2021) & (US$ Million)
Table 76. Hikma Pharmaceuticals Recent Development
Table 77. Baxter Company Details
Table 78. Baxter Business Overview
Table 79. Baxter Osteosarcoma Product
Table 80. Baxter Revenue in Osteosarcoma Business (2016-2021) & (US$ Million)
Table 81. Baxter Recent Development
Table 82. Isofol Company Details
Table 83. Isofol Business Overview
Table 84. Isofol Osteosarcoma Product
Table 85. Isofol Revenue in Osteosarcoma Business (2016-2021) & (US$ Million)
Table 86. Isofol Recent Development
Table 87. Advaxis Company Details
Table 88. Advaxis Business Overview
Table 89. Advaxis Osteosarcoma Product
Table 90. Advaxis Revenue in Osteosarcoma Business (2016-2021) & (US$ Million)
Table 91. Advaxis Recent Development
Table 92. Bellicum Pharmaceuticals Company Details
Table 93. Bellicum Pharmaceuticals Business Overview
Table 94. Bellicum Pharmaceuticals Osteosarcoma Product
Table 95. Bellicum Pharmaceuticals Revenue in Osteosarcoma Business (2016-2021) & (US$ Million)
Table 96. Bellicum Pharmaceuticals Recent Development
Table 97. Novartis Company Details
Table 98. Novartis Business Overview
Table 99. Novartis Revenue in Osteosarcoma Business (2016-2021) & (US$ Million)
Table 100. Novartis Recent Development
Table 101. Research Programs/Design for This Report
Table 102. Key Data Information from Secondary Sources
Table 103. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Osteosarcoma Market Share by Type: 2020 VS 2027
Figure 2. Intramedullary Osteosarcoma Features
Figure 3. Juxtacortical Osteosarcoma Features
Figure 4. Extraskeletal Osteosarcoma Features
Figure 5. Global Osteosarcoma Market Share by Application: 2020 VS 2027
Figure 6. Hospital Case Studies
Figure 7. Clinic Case Studies
Figure 8. Others Case Studies
Figure 9. Osteosarcoma Report Years Considered
Figure 10. Global Osteosarcoma Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 11. Global Osteosarcoma Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 12. Global Osteosarcoma Market Share by Regions: 2020 VS 2027
Figure 13. Global Osteosarcoma Market Share by Regions (2022-2027)
Figure 14. Global Osteosarcoma Market Share by Players in 2020
Figure 15. Global Top Osteosarcoma Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Osteosarcoma as of 2020
Figure 16. The Top 10 and 5 Players Market Share by Osteosarcoma Revenue in 2020
Figure 17. Global Osteosarcoma Revenue Market Share by Type (2016-2021)
Figure 18. Global Osteosarcoma Revenue Market Share by Type (2022-2027)
Figure 19. North America Osteosarcoma Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 20. North America Osteosarcoma Market Share by Type (2016-2027)
Figure 21. North America Osteosarcoma Market Share by Application (2016-2027)
Figure 22. North America Osteosarcoma Market Share by Country (2016-2027)
Figure 23. United States Osteosarcoma Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Canada Osteosarcoma Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Osteosarcoma Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Osteosarcoma Market Share by Type (2016-2027)
Figure 27. Europe Osteosarcoma Market Share by Application (2016-2027)
Figure 28. Europe Osteosarcoma Market Share by Country (2016-2027)
Figure 29. Germany Osteosarcoma Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. France Osteosarcoma Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. U.K. Osteosarcoma Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Italy Osteosarcoma Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Russia Osteosarcoma Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Nordic Osteosarcoma Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Osteosarcoma Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Osteosarcoma Market Share by Type (2016-2027)
Figure 37. Asia-Pacific Osteosarcoma Market Share by Application (2016-2027)
Figure 38. Asia-Pacific Osteosarcoma Market Share by Region (2016-2027)
Figure 39. China Osteosarcoma Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Japan Osteosarcoma Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. South Korea Osteosarcoma Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Southeast Asia Osteosarcoma Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. India Osteosarcoma Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Australia Osteosarcoma Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Osteosarcoma Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Osteosarcoma Market Share by Type (2016-2027)
Figure 47. Latin America Osteosarcoma Market Share by Application (2016-2027)
Figure 48. Latin America Osteosarcoma Market Share by Country (2016-2027)
Figure 49. Mexico Osteosarcoma Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Brazil Osteosarcoma Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Osteosarcoma Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Osteosarcoma Market Share by Type (2016-2027)
Figure 53. Middle East & Africa Osteosarcoma Market Share by Application (2016-2027)
Figure 54. Middle East & Africa Osteosarcoma Market Share by Country (2016-2027)
Figure 55. Turkey Osteosarcoma Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Saudi Arabia Osteosarcoma Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. UAE Osteosarcoma Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Pfizer Revenue Growth Rate in Osteosarcoma Business (2016-2021)
Figure 59. Spectrum Pharmaceuticals Revenue Growth Rate in Osteosarcoma Business (2016-2021)
Figure 60. Hikma Pharmaceuticals Revenue Growth Rate in Osteosarcoma Business (2016-2021)
Figure 61. Baxter Revenue Growth Rate in Osteosarcoma Business (2016-2021)
Figure 62. Isofol Revenue Growth Rate in Osteosarcoma Business (2016-2021)
Figure 63. Advaxis Revenue Growth Rate in Osteosarcoma Business (2016-2021)
Figure 64. Bellicum Pharmaceuticals Revenue Growth Rate in Osteosarcoma Business (2016-2021)
Figure 65. Novartis Revenue Growth Rate in Osteosarcoma Business (2016-2021)
Figure 66. Bottom-up and Top-down Approaches for This Report
Figure 67. Data Triangulation
Figure 68. Key Executives Interviewed
世界の放射免疫療法市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Radioimmunotherapy Market The global Radioimmunotherapy market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analysis and high data integrity, the report makes…- 世界のシスプラチン市場規模・現状・予測（2021年-2027年） Cisplatin is one of the most commonly used drugs in current combined chemotherapy. Its chemical name is cis-dichlorodiaminoplatin, which is an inorganic metal complex. After chlorine dissociation, it cross-connects with the DNA of cancer cells, thus damaging the function of DNA.It may form intracycl…
- 世界のシスプラチン市場規模・現状・予測（2021年-2027年） Cisplatin is one of the most commonly used drugs in current combined chemotherapy. Its chemical name is cis-dichlorodiaminoplatin, which is an inorganic metal complex. After chlorine dissociation, it cross-connects with the DNA of cancer cells, thus damaging the function of DNA.It may form intracycl…
- 世界の髄内ロッド市場 2021：企業別、地域別、種類・用途別 The Intramedullary Rod market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations,…
- 世界の漢方薬市場規模・現状・予測（2021年-2027年） Traditional Chinese Medicine (TCM), a discipline dealing with the study of physiology, pathology, diagnosis and prevention and treatment of diseases. Market Analysis and Insights: Global Traditional Chinese Medicine Market The global Traditional Chinese Medicine market size is projected to reach US$…